Related Experiment Video
Updated: Sep 21, 2025
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
Identification of common key genes associated with Crohn's Disease and IgA nephropathy
1Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. 11618152@zju.edu.cn.
Objective:
Emerging studies have suggested a strong link between Crohn's disease (CD) and IgA nephropathy (IgAN), but the underlying pathogenesis remains unclear. This led us to explore the common pathogenic genes for the two diseases by originally applying a bioinformatic method.
Materials And Methods:
The CD and IgAN datasets were downloaded from the Gene Expression Omnibus (GEO) database. The common differentially expressed genes (DEGs) of the two diseases were identified. GO and KEGG enrichment analyses for the common DEGs were further performed. Then, PPI networks were constructed to identify the hub genes. Afterwards, the receiver operating characteristic (ROC) curves were constructed to assess the diagnostic value of the hub genes. Finally, the immune infiltrations in the samples were analyzed and the correlation of the hub genes with the immune infiltration was studied.
Results:
47 common DEGs were identified between CD and IgAN with the threshold of p-value < 0.05 and |log2FC| > 1. The top 5 GO terms and 5 KEGG pathways were displayed, and the top 10 hub genes were selected. The diagnostic value of these hub genes was evaluated by calculating the area under the ROC curves. Among the hub genes, CXCL2 was not only identified as the common hub gene, but also with the highest diagnostic value. Finally, CXCL2 was verified to be crucially correlated with the immune infiltration in the samples of CD and IgAN.
Conclusions:
Our study identified critical pathogenic genes commonly responsible for the pathogenesis of CD and IgAN, which provided novel biomarkers and promising therapeutic targets for the two diseases. Further experimental and clinical research are needed to verify our results.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:11Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents